AGIO
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Company Sector
Cardio-Metabolic
24 companies tagged with Cardio-Metabolic.
Cardio-Metabolic includes companies targeting cardiovascular disease, obesity, diabetes, lipid disorders, and related metabolic conditions. This page highlights businesses exposed to some of the largest and most competitive treatment categories in biotech and pharma.
AMGN
Amgen Inc.
Amgen is a large-cap biopharmaceutical company with a commercial base spanning oncology, inflammation, bone health, cardiovascular disease, and rare disease. Investors follow the stock for the mix of marketed products, late-stage pipeline optionality, and recurring regulatory or launch milestones.
AZN
AstraZeneca PLC
AstraZeneca is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
BMY
BMYBristol-Myers Squibb Company
Bristol Myers Squibb is a large-cap biopharmaceutical company with a portfolio spanning oncology, hematology, immunology, and cardiovascular disease. The market watches the stock for commercial durability, pipeline replacement, and the pace at which new assets offset lifecycle pressure.
CORT
Corcept
Corcept is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
EW
Edwards Lifesciences
Edwards Lifesciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
LLY
Eli Lilly
Eli Lilly is a large-cap pharmaceutical company with major exposure to cardiometabolic disease, neuroscience, and oncology. Investors track the stock for commercial scale, label expansion, and a pipeline that still carries meaningful growth optionality.
FRX
Forest Laboratories
Forest Laboratories is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
GSK
GSK plc
GSK plc is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
BEAT
HeartBeam
HeartBeam is a cardiometabolic biopharmaceutical company focused on long-duration disease areas where efficacy, access, and long-term adoption all matter to investors.
HSCS
HeartSciences
HeartSciences is a cardiometabolic biopharmaceutical company focused on long-duration disease areas where efficacy, access, and long-term adoption all matter to investors.
JNJ
Johnson & Johnson
Johnson & Johnson is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
MTCR
Metacrine
Metacrine is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
MIST
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
NAMS
NewAmsterdam Pharma
NewAmsterdam Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
NVS
Novartis AG
Novartis AG is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
PFE
Pfizer, Inc.
Pfizer is a global pharmaceutical company with a diversified portfolio across vaccines, internal medicine, oncology, and other specialty areas. Investors track the stock for commercial scale, pipeline renewal, and the pace at which major programs translate into growth.
RSLS
ReShape Lifesciences
ReShape Lifesciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
SNY
Sanofi
Sanofi is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
SWAV
Shockwave Medical
Shockwave Medical is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
TCDA
Tricida
Tricida is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
VERV
Verve Therapeutics
Verve Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
VTRS
Viatris Inc.
Viatris is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
VKTX
Viking Therapeutics
Viking Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.